首页> 美国卫生研究院文献>other >A VERSATILE BIFUNCTIONAL CHELATE FOR RADIOLABELING HUMANIZED ANTI-CEA ANTIBODY WITH IN-111 AND CU-64 AT EITHER THIOL OR AMINO GROUPS: PET IMAGING OF CEA-POSITIVE TUMORS WITH WHOLE ANTIBODIES
【2h】

A VERSATILE BIFUNCTIONAL CHELATE FOR RADIOLABELING HUMANIZED ANTI-CEA ANTIBODY WITH IN-111 AND CU-64 AT EITHER THIOL OR AMINO GROUPS: PET IMAGING OF CEA-POSITIVE TUMORS WITH WHOLE ANTIBODIES

机译:在所有硫醇或氨基上均用放射性标记的人源化抗CEA抗体与IN-111和CU-64的多功能螯合物:带有全抗原的CEA阳性肿瘤的PET成像

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Radiolabeled anti-carcinoembryonic antigen (CEA) antibodies have the potential to give excellent images of a wide variety of human tumors, including tumors of the colon, breast, lung, and medullar thyroid. In order to realize the goals of routine and repetitive clinical imaging with anti-CEA antibodies, it is necessary that the antibodies have high affinity for CEA, low cross reactivity and uptake in normal tissues, and low immunogenicity. The humanized anti-CEA antibody hT84.66-M5A (M5A) fulfills these criteria with an affinity constant >1010 M−1, no reactivity with CEA cross-reacting antigens found in normal tissues, and >90% human protein sequence. A further requirement for routine clinical use of radiolabeled antibodies is a versatile method of radiolabeling that allows the use of multiple radionuclides that differ in their radioemissions and half-lives. We describe a versatile bifunctional chelator, DO3A-VS (1, 4, 7-tris(carboxymethyl)-10-(vinylsulfone)-1, 4, 7, 10-tetraazacyclododecane) that binds a range of radiometals including 111In for gamma-ray imaging and 64Cu for Positron Emission Tomography (PET), and which can be conjugated with negligible loss of immunoreactivity either to sulfhydryls (SH) in the hinge region of lightly reduced immunoglobulins or surface lysines (NH) of immunoglobulins.MethodsAthymic mice peripherally xenografted with CEA-positive human colon tumors (LS-174T) were injected with 111In-labeled or 64Cu-labeled SH-DO3A-VS-M5A, NH-DO3A-VS-M5A, or DOTA-M5A and sacrificed at various time points for biodistribution measurements. Other mice injected with 64Cu-labeled SH-DO3A-VS-M5A or NH-DO3A-VS-M5A were imaged serially with small animal PET from 1 to 48 h post injection and then sacrificed for biodistribution measurements.
机译:放射性标记的抗癌胚抗原(CEA)抗体具有为多种人类肿瘤(包括结肠,乳腺,肺和甲状腺髓样肿瘤)提供出色图像的潜力。为了实现使用抗CEA抗体进行常规和重复性临床成像的目标,有必要使抗体对CEA具有高亲和力,在正常组织中具有较低的交叉反应性和摄取,并且具有较低的免疫原性。人源化抗CEA抗体hT84.66-M5A(M5A)满足这些标准,亲和常数> 10 10 M -1 ,与CEA交叉反应抗原无反应性在正常组织中发现,且人类蛋白序列> 90%。放射标记抗体的常规临床使用的另一要求是放射标记的通用方法,该方法允许使用其放射发射和半衰期不同的多种放射性核素。我们描述了一种通用的双功能螯合剂DO3A-VS(1、4、7-三(羧甲基)-10-(乙烯基砜)-1、4、7、10-四氮杂环十二烷),可与包括 111 < / sup> In用于伽马射线成像, 64 Cu用于正电子发射断层扫描(PET),并且可以与略微减少的铰链区中巯基(SH)的免疫反应性损失共轭方法对在CEA阳性人类结肠肿瘤(LS-174T)周围异种移植的胸腺小鼠注射 111 In标记或 64 Cu标记的SH-DO3A-VS-M5A,NH-DO3A-VS-M5A或DOTA-M5A,并在各个时间点牺牲以进行生物分布测量。在注射后1至48小时,用小动物PET对其他注射了 64 Cu标记的SH-DO3A-VS-M5A或NH-DO3A-VS-M5A的小鼠进行连续成像,然后处死以进行生物分布测量。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号